Industry News
BresaGen wins FDA approval for catheter
In a step towards improved application of cell therapies, South Australian company BresaGen has gained US Food and Drug Administration approval to market a catheter designed for the delivery of therapeutics to the brain. [ + ]
What's really in sea water? More than just salt!
Recent studies by scientists at ANSTO, have revealed some startling discoveries about what really constitutes the water in our neighbouring oceans.
[ + ]Chemeq raises $8m
Chemeq has raised $8 million in its latest placement to institutions and other sophisticated investors, bringing the total raised this year to $15.5 million. [ + ]
Skin surface laser patent granted to Norwood
Drug delivery group Norwood Abbey has added another patent to its portfolio, the latest covering laser technology to alter the skin's surface. [ + ]
Cell death key discovered by Monash Institute
Melbourne researchers have uncovered a new genetic player in programmed cell death, offering a fresh target for potential cancer therapies. [ + ]
Euro decision disappoints Stem Cell Sciences
A decision by the European Patent Office (EPO) to revise the controversial 'Edinburgh' patent to exclude embryonic stem cells has disappointed Australian company Stem Cell Sciences. [ + ]
Mayne backs new brain centre
A new Sydney imaging centre is set to improve research opportunities for brain and nervous system specialists. [ + ]
Discovery raises hopes for bone disease sufferers
Monash University researchers have identified two basic mechanisms that control the level of calcium deposition in bones and joints, a finding that could lead to treatments for osteoporosis and some forms of arthritis.
[ + ]IT awards seeking bio-IT involvement
Bio-IT innovators are being encouraged to enter this year's Asia-Pacific Australian Information Communication and Technology (ICT) Awards. [ + ]
EQiTX, Starphama appoint heavy hitters
Born-again oil exploration company EQiTX has added another science heavyweight to its ranks for its latest incarnation as a biotech. [ + ]
Optiscan appoints new chairman
A new chairman with science and manufacturing experience is to head the board of Optiscan. [ + ]
Aventis CropScience becomes Bayer CropScience
Aventis CropScience has officially become Bayer CropScience as a result of last year's acquisition of the CropScience unit by Bayer for around 7.25 billion euros ($AU13.4 billion). [ + ]
Monash researchers in osteoporosis find
An international collaboration including Melbourne researchers has uncovered two reasons for calcium deposits in bones and joints, setting the foundation for new osteoporosis therapies. [ + ]
Gradipore's Texan work nears completion
Sydney bioseparations specialist Gradipore has revealed that the first stage of its collaborative work with Texas A&M University is nearing completion. [ + ]
Innovation patent system gets a workout
Patent attorneys will be watching closely this week as the legal status of the Federal Government's innovation patents system is tested for the first time in court. [ + ]
